71 related articles for article (PubMed ID: 22931600)
21. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
22. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
23. [Effects of mitofusin-2 gene on proliferation and chemosensitivity of human breast carcinoma cell line MCF-7].
Xia Y; Wu YQ; Zhang L; Li XL; Yuan HL; He XJ; Tao DD; Gong JP; Qiu FZ
Ai Zheng; 2007 Aug; 26(8):815-9. PubMed ID: 17697539
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Calvo V; Beato M
Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
[TBL] [Abstract][Full Text] [Related]
25. Enhanced motility of KGF-transfected breast cancer cells.
Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT
Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493
[TBL] [Abstract][Full Text] [Related]
26. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
27. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A
Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289
[TBL] [Abstract][Full Text] [Related]
28. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
29. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
[TBL] [Abstract][Full Text] [Related]
30. [Effects of interferon-gamma on Her-2/neu expression and antitumor activity of 131I-Herceptin in breast cancer cell lines].
Fan YX; Luo RC; Fang YX; Yan X; Lu CW
Ai Zheng; 2006 Apr; 25(4):443-6. PubMed ID: 16613677
[TBL] [Abstract][Full Text] [Related]
31. [Progesterone promotes the proliferation and migration of cultured breast cancer cells].
Zhao JJ; Wang X; Huo ZJ; Luo SQ; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):443-6. PubMed ID: 20335105
[TBL] [Abstract][Full Text] [Related]
32. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
33. SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
Zang XP; Pento JT
Anticancer Res; 2008; 28(5A):2733-5. PubMed ID: 19035303
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
35. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells.
López-Marure R; Contreras PG; Dillon JS
Eur J Pharmacol; 2011 Jun; 660(2-3):268-74. PubMed ID: 21497598
[TBL] [Abstract][Full Text] [Related]
36. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
37. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
38. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.
Favy DA; Rio P; Maurizis JC; Hizel C; Bignon YJ; Bernard-Gallon DJ
Biochem Biophys Res Commun; 1999 May; 258(2):284-91. PubMed ID: 10329379
[TBL] [Abstract][Full Text] [Related]
39. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
40. [BRCA1 selectively regulates the expression of progesterone receptor A in sporadic invasive ductal breast carcinoma].
Wang X; Zhao T; Zhao JJ; Xiong JB
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1399-402. PubMed ID: 20646629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]